- 全部删除
您的购物车当前为空
Plozalizumab (MLN-1202) 是一种人源化具有选择性和有效性的抗 CCR2 抗体。Plozalizumab 具有抗肿瘤活性。Plozalizumab 可用于研究恶性黑色素瘤。


为众多的药物研发团队赋能,
让新药发现更简单!
Plozalizumab (MLN-1202) 是一种人源化具有选择性和有效性的抗 CCR2 抗体。Plozalizumab 具有抗肿瘤活性。Plozalizumab 可用于研究恶性黑色素瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,980 | In stock | |
| 5 mg | ¥ 5,130 | In stock | |
| 10 mg | ¥ 6,930 | In stock | |
| 25 mg | ¥ 10,500 | In stock | |
| 50 mg | ¥ 13,900 | In stock |
Plozalizumab 相关产品
| 产品描述 | Plozalizumab (MLN-1202) is a humanized selective and potent anti-CCR2 antibody.Plozalizumab has antitumor activity.Plozalizumab is used in the study of malignant melanoma. |
| 别名 | 洛扎利珠单抗, MLN-1202 |
| 分子量 | 146.02 kDa |
| CAS No. | 1610761-46-0 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容